Effects of Vildagliptin on Glucose Control in Patients with Type 2 Diabetes Inadequately Controlled With Metformin

Journal Title: Journal of Medical Science And clinical Research - Year 2015, Vol 3, Issue 6

Abstract

Aim and Objective: We sought to evaluate the efficacy and safety of vildagliptin, a new dipeptidyl peptidase-4 inhibitor, added to metformin during 24 weeks of treatment in patients with type 2 diabetes. Patient selection and method: The study was done in 100 patients of Type 2 DM who were inadequately controlled by metformin alone. Strict predefined inclusion and exclusion criteria were followed and each patient was monitored with physical examination including body weight and blood pressure, complete blood count, fasting blood glucose and post prandial blood glucose, HbA1c, lipid profile (TC, LDL – C, HDL – C, triglycerides), renal profile (B Urea, S Creatinine, routine urine examination, ACR – urine, test for microalbuminemia), liver profile (ALT, AST, ALP, S.Bilirubin, S Protein) and ECG. Efficacy and tolerability were assessed in eight visits over 24 weeks. Results: The decrease of mean HbA1c level was 1.13% in cases (Group A) as compared to 0.05% in the control (Group B) at 24 week which was found to be significant (P value <0.01). Reduction in the mean fasting blood glucose level in cases (Group A) was 28.83mg/dL as compared to 3.6mg/dL in control (Group B) at 24 weeks. This decrease was found to be significant (P value <0.01). Reduction in the mean post prandial blood glucose level in cases (Group A) was 41.44mg/dL as compared to 2.12mg/dL in control (Group B) at 24 week. This decrease was found to be significant (P value <0.01). No major changes from baseline to endpoint were observed for any hematological, biochemical or urinalysis parameter. Conclusion: Vildagliptin is well tolerated and produces clinically meaningful, dose-related decreases in A1C and FPG as add-on therapy in patients with type 2 diabetes inadequately controlled by metformin.

Authors and Affiliations

Dr Abhishek Anand

Keywords

Related Articles

MRI in Diagnosis of Prostate Carcinoma

Carcinoma of Prostrate is a commonly diagnosed tumour in males that represents a broad spectrum of severity, ranging from asymptomatic to highly lethal. The utilisation of prostate-specific antigen (PSA) serum screening...

A Case Report of Rhino-Orbital-Cerebral Mucormycosis

Rhino-orbital-cerebral mucormycosis is a rare but life threatening infection that generally occurs in patients with diabetes mellitus and other immune deficiency conditions. Rhino-orbital and Rhino-cerebral are two form...

Speech Enhancing Prosthesis for Acquired Cleft Palate

Cleft of the hard palate that is acquired secondary to surgical correction of a carcinoma renders the patient handicapped relative to phonetics. Obturation of such defects, temporarily or permanently are essential initia...

Acute Rheumatic Fever with Erythema Marginatum-Case Report

Acute rheumatic fever (ARF) is a multisystem disease resulting from an autoimmune reaction to infection with group A streptococcus. Carditis (clinical/subclinical), Arthritis (polyarthritis, mono arthritis, arthralgia),...

Ectopic Gall Bladder Associated With Segmental Hypoplasia of Right Lobe of Liver: Two Cases

The gallbladder is a pear shaped organ lying in the inferior margin of liver, between the right and left lobes. Its primary function is to store and concentrate bile produced by the liver. The gallbladder is affected by...

Download PDF file
  • EP ID EP209089
  • DOI -
  • Views 48
  • Downloads 0

How To Cite

Dr Abhishek Anand (2015). Effects of Vildagliptin on Glucose Control in Patients with Type 2 Diabetes Inadequately Controlled With Metformin. Journal of Medical Science And clinical Research, 3(6), 5963-5976. https://europub.co.uk/articles/-A-209089